BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 10, 2026
Home » Authors » Randy Osborne

Articles by Randy Osborne

Go-Private Strategy Offers Fix For Firms Out Of Favor'

Jan. 15, 2007
By Randy Osborne

CEO: Pharmion Has Evolved, Could 'Transform' During '07

Jan. 11, 2007
By Randy Osborne
SAN FRANCISCO - As day three of the decidedly upbeat JPMorgan Healthcare Conference began, Bay Area fog burned off and the sun shone bright, but forecasters warned of an approaching cold wave. (BioWorld Today)
Read More

INEX Flexes Muscle By Way Of Broadened Alnylam Deal

Jan. 10, 2007
By Randy Osborne
SAN FRANCISCO - Long known as the venue where many deals quietly begin, the JPMorgan Healthcare Conference also can be the place where the world finds out about existing relationships that just got better. (BioWorld Today)
Read More

Catalyst, Wyeth Deal: Up To $100M For Protease Targets

Jan. 9, 2007
By Randy Osborne

Despite Decades Of Change, Industry Tradition Carries On

Jan. 8, 2007
By Randy Osborne

Pancreatic Cancer Research On Threshold' Of Progress?

Jan. 8, 2007
By Randy Osborne

Caprion, Ecopia Plan Merger; C$30M Placement Also Due

Jan. 5, 2007
By Randy Osborne

Genentech Paying Exelixis $40M In MEK Inhibitor Deal

Jan. 4, 2007
By Randy Osborne

2006: Industry Holds Steady, Consolidates, Gathers Steam

Jan. 1, 2007
By Randy Osborne

Telik's Shares Take Tumble On Telcyta Phase III Failures

Dec. 27, 2006
By Randy Osborne
Analysts pelted Telik Inc. officials with questions they couldn't answer yet during a conference call on preliminary failure data from Phase III trials with the cancer drug Telcyta, and Wall Street smacked down the company's stock by 70.7 percent. (BioWorld Today)
Read More
Previous 1 2 … 346 347 348 349 350 351 352 353 354 … 474 475 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 9, 2026.
  • China compass

    ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

    BioWorld
    If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing